4.6 Review

Traction of 3D and 4D Printing in the Healthcare Industry: From Drug Delivery and Analysis to Regenerative Medicine

期刊

ACS BIOMATERIALS SCIENCE & ENGINEERING
卷 8, 期 7, 页码 2764-2797

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.2c000942764

关键词

bioprinting; 3D-printed technology; 4D printing technology; microfluidics

资金

  1. Australian Government Research Training Program
  2. NHMRC [2002723]

向作者/读者索取更多资源

This review explores the potential and applications of 3D printing and 3D bioprinting in healthcare, including the production of personalized products, patient-specific tissues, and organ-on-chip constructs. It also discusses how tailoring parameters and adopting dynamic 4D printing strategies can optimize and overcome limitations of conventional 3D printing technologies.
Three-dimensional (3D) printing and 3D bioprinting are promising technologies for a broad range of healthcare applications from frontier regenerative medicine and tissue engineering therapies to pharmaceutical advancements yet must overcome the challenges of biocompatibility and resolution. Through comparison of traditional biofabrication methods with 3D (bio)printing, this review highlights the promise of 3D printing for the production of on-demand, personalized, and complex products that enhance the accessibility, effectiveness, and safety of drug therapies and delivery systems. In addition, this review describes the capacity of 3D bioprinting to fabricate patient-specific tissues and living cell systems (e.g., vascular networks, organs, muscles, and skeletal systems) as well as its applications in the delivery of cells and genes, microfluidics, and organ-on-chip constructs. This review summarizes how tailoring selected parameters (i.e., accurately selecting the appropriate printing method, materials, and printing parameters based on the desired application and behavior) can better facilitate the development of optimized 3D-printed products and how dynamic 4D-printed strategies (printing materials designed to change with time or stimulus) may be deployed to overcome many of the inherent limitations of conventional 3D-printed technologies. Comprehensive insights into a critical perspective of the future of 4D bioprinting, crucial requirements for 4D printing including the programmability of a material, multimaterial printing methods, and precise designs for meticulous transformations or even clinical applications are also given.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据